首页> Clinical Pharmacology and Therapeutics> PHARMACOKINETIC ANALYSIS OF beta-GLUCAN FOLLOWING ADMINISTRATION OF PGG-GLUCAN, A NOVEL IMMUNOMODULATOR BEING DEVELOPED FOR THE TREATMENT OF NON-SMALL CELL LUNG CANCER.

PHARMACOKINETIC ANALYSIS OF beta-GLUCAN FOLLOWING ADMINISTRATION OF PGG-GLUCAN, A NOVEL IMMUNOMODULATOR BEING DEVELOPED FOR THE TREATMENT OF NON-SMALL CELL LUNG CANCER.

导出原文传递

翻译打印收藏纠错

第一作者： Marier, J. F.

作者： Marier, J. F. ^[1] ; Jomphe, C. ^[2] ; Beliveau, M. ; Lowe, J. ; Mattson, P. ; Walsh, R. ; Patchen, M. L.

作者单位： Pharsight Consulting Serv, Montreal, PQ, Canada ^[1] Biothera, Eagan, MN USA ^[2]

发布时间 2020-08-22

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Clinical Pharmacology and Therapeutics

2014年95卷Suppl.1期

S32-S33页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览0

点击下载本期目录封面

Clinical Pharmacology and Therapeutics

2014年95卷Suppl.1期

S32-S33页

检索历史清除

PHARMACOKINETIC ANALYSIS OF beta-GLUCAN FOLLOWING ADMINISTRATION OF PGG-GLUCAN, A NOVEL IMMUNOMODULATOR BEING DEVELOPED FOR THE TREATMENT OF NON-SMALL CELL LUNG CANCER.

Clinical Pharmacology and Therapeutics

相似文献

同项目论文

Clinical Pharmacology and Therapeutics

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

PHARMACOKINETIC ANALYSIS OF beta-GLUCAN FOLLOWING ADMINISTRATION OF PGG-GLUCAN, A NOVEL IMMUNOMODULATOR BEING DEVELOPED FOR THE TREATMENT OF NON-SMALL CELL LUNG CANCER.

Clinical Pharmacology and Therapeutics

相似文献

同项目论文

Clinical Pharmacology and Therapeutics

相关期刊

检索历史清除